Chronic Pain Treatments

Find Chronic Pain Treatments

Generic Name

OxyCODONE

Brand Names

HYDROcodone, Butalbital, TraMADol, Endocet, Tencon, OxyContin, Percocet, HYDROcodone APAP, Nalocet, Oxaydo, Allzital, Fioricet, Xtampza, Homatropine Methylbromide, ConZip, Ascomp, RoxyBond, Hysingla, Butal, Roxicodone, Norco

FDA approval date: December 07, 1983

Classification: Opioid Agonist

Form: Liquid, Tablet, Capsule, Solution

What is HYDROcodone (OxyCODONE)?

Oxycodone hydrochloride tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see Warnings and Precautions.

Approved To Treat

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

Long Term Follow-up of the TREOCAPA (Prophylactic TREatment Of the duCtus Arteriosus in Preterm Infants by Acetaminophen) Study (TREOCAPA-LT)

Enrollment Status: Recruiting

Publish Date: April 16, 2026

Intervention Type: Other

Summary: The ductus arteriosus (DA) is a large channel connecting the main pulmonary trunk with the descending aorta. In extremely preterm infants, the DA frequently fails to close and this results in a condition called patent ductus arteriosus (PDA). In these patients, PDA has been associated with increased mortality and morbidity in the neonatal period, and neonatal morbidities may in turn be associated ...

A Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan Maintenance Treatment With or Without Bevacizumab Versus Standard of Care After Second-line Platinum-based Doublet Chemotherapy in Participants With Platinum-sensitive Recurrent Ovarian Cancer (TroFuse-022/ENGOT-ov84/GOG-3103)

Enrollment Status: Recruiting

Publish Date: April 16, 2026

Intervention Type: Drug, Biological

Study Phase: Phase 3

Summary: The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and if people who take sacituzumab tirumotecan with or without bevacizumab live longer without the cancer getting worse than those who receive standard of care treatment.

Safety, Tolerability and Efficacy Against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults

Enrollment Status: Recruiting

Publish Date: April 16, 2026

Intervention Type: Other, Biological

Study Phase: Phase 1

Summary: This is a first-in-human, randomized, double-blind, placebo-controlled Phase 1 trial of Plasmodium falciparum (Pf) sporozoite (SPZ) late-arresting replication-competent (LARC) malaria vaccine (PfSPZ-LARC2 Vaccine) administered to healthy, malaria-naive study participants in Germany by direct venous inoculation (DVI) to determine safety, tolerability, and vaccine efficacy (VE) against controlled hu...

View All Clinical Trials